Abstract
Suppression of an excessive systemic inflammatory response is a promising and potent strategy for treating endotoxic sepsis. Indoleamine 2,3-dioxygenase (IDO), which is the rate-limiting enzyme for tryptophan catabolism, may play a critical role in various inflammatory disorders. In this study, we report a critical role for IDO in the dysregulated immune response associated with endotoxin shock. We found that IDO knockout (IDO-/-) mice and 1-methyl-D-tryptophan-treated, endotoxin-shocked mice had decreased levels of the cytokines, TNF-α, IL-6, and IL-12, and enhanced levels of IL-10. Blockade of IDO is thought to promote host survival in LPS-induced endotoxin shock, yet little is known about the molecular mechanisms that regulate IDO expression during endotoxin shock. In vitro and in vivo, IDO expression was increased by exogenous IL-12, but decreased by exogenous IL-10 in dendritic cells and splenic dendritic cells. Interestingly, whereas LPS-induced IL-12 levels in serum were higher than those of IL-10, the balance between serum IL-12 and IL-10 following challenge became reversed in IDO-/-- or 1-methyl-D-tryptophan-treated mice. Our findings demonstrate that the detrimental immune response to endotoxin shock may occur via IDO modulation. Restoring the IL-12 and IL-10 balance by blocking IDO represents a potential strategy for sepsis treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 3146-3154 |
| Number of pages | 9 |
| Journal | Journal of Immunology |
| Volume | 182 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2009 Mar 1 |
Fingerprint
ASJC Scopus subject areas
- Immunology
Cite this
Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock. / Jung, In Duk; Lee, Min-Goo; Chang, Jeong Hyun; Lee, Jun Sik; Jeong, Young Il; Lee, Chang Min; Park, Won Sun; Han, Jin; Seo, Su Kil; Lee, Sang Yong; Park, Yeong Min.
In: Journal of Immunology, Vol. 182, No. 5, 01.03.2009, p. 3146-3154.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock
AU - Jung, In Duk
AU - Lee, Min-Goo
AU - Chang, Jeong Hyun
AU - Lee, Jun Sik
AU - Jeong, Young Il
AU - Lee, Chang Min
AU - Park, Won Sun
AU - Han, Jin
AU - Seo, Su Kil
AU - Lee, Sang Yong
AU - Park, Yeong Min
PY - 2009/3/1
Y1 - 2009/3/1
N2 - Suppression of an excessive systemic inflammatory response is a promising and potent strategy for treating endotoxic sepsis. Indoleamine 2,3-dioxygenase (IDO), which is the rate-limiting enzyme for tryptophan catabolism, may play a critical role in various inflammatory disorders. In this study, we report a critical role for IDO in the dysregulated immune response associated with endotoxin shock. We found that IDO knockout (IDO-/-) mice and 1-methyl-D-tryptophan-treated, endotoxin-shocked mice had decreased levels of the cytokines, TNF-α, IL-6, and IL-12, and enhanced levels of IL-10. Blockade of IDO is thought to promote host survival in LPS-induced endotoxin shock, yet little is known about the molecular mechanisms that regulate IDO expression during endotoxin shock. In vitro and in vivo, IDO expression was increased by exogenous IL-12, but decreased by exogenous IL-10 in dendritic cells and splenic dendritic cells. Interestingly, whereas LPS-induced IL-12 levels in serum were higher than those of IL-10, the balance between serum IL-12 and IL-10 following challenge became reversed in IDO-/-- or 1-methyl-D-tryptophan-treated mice. Our findings demonstrate that the detrimental immune response to endotoxin shock may occur via IDO modulation. Restoring the IL-12 and IL-10 balance by blocking IDO represents a potential strategy for sepsis treatment.
AB - Suppression of an excessive systemic inflammatory response is a promising and potent strategy for treating endotoxic sepsis. Indoleamine 2,3-dioxygenase (IDO), which is the rate-limiting enzyme for tryptophan catabolism, may play a critical role in various inflammatory disorders. In this study, we report a critical role for IDO in the dysregulated immune response associated with endotoxin shock. We found that IDO knockout (IDO-/-) mice and 1-methyl-D-tryptophan-treated, endotoxin-shocked mice had decreased levels of the cytokines, TNF-α, IL-6, and IL-12, and enhanced levels of IL-10. Blockade of IDO is thought to promote host survival in LPS-induced endotoxin shock, yet little is known about the molecular mechanisms that regulate IDO expression during endotoxin shock. In vitro and in vivo, IDO expression was increased by exogenous IL-12, but decreased by exogenous IL-10 in dendritic cells and splenic dendritic cells. Interestingly, whereas LPS-induced IL-12 levels in serum were higher than those of IL-10, the balance between serum IL-12 and IL-10 following challenge became reversed in IDO-/-- or 1-methyl-D-tryptophan-treated mice. Our findings demonstrate that the detrimental immune response to endotoxin shock may occur via IDO modulation. Restoring the IL-12 and IL-10 balance by blocking IDO represents a potential strategy for sepsis treatment.
UR - http://www.scopus.com/inward/record.url?scp=64849108173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=64849108173&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.0803104
DO - 10.4049/jimmunol.0803104
M3 - Article
C2 - 19234212
AN - SCOPUS:64849108173
VL - 182
SP - 3146
EP - 3154
JO - Journal of Immunology
JF - Journal of Immunology
SN - 0022-1767
IS - 5
ER -